<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twelve patients with unfavorable prognosis <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (diffuse histiocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 11; nodular histiocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 1) treated predominantly with radiation therapy, are described in whom relapse of disease occurred late (greater than 2.5 years, 2.8-26 years; median, 6.25 years) after achieving a complete remission </plain></SENT>
<SENT sid="1" pm="."><plain>Although relapse probably represented regrowth of clinically quiescent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, it is also possible that these were <z:e sem="disease" ids="C0085183" disease_type="Neoplastic Process" abbrv="">second malignancies</z:e>, perhaps occurring in a predisposed host </plain></SENT>
<SENT sid="2" pm="."><plain>Continued long-term analysis of clinical trials is important to document this uncommon occurrence </plain></SENT>
</text></document>